Coeptis Therapeutics Inc (COEP) Financials

$15.20

$-1.20 (-7.32%)

As on 27-Apr-2026 09:30EDT

Market cap

$102 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

7.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-05	Dec-04
Operating Revenue	1.41	1.36	--	--	--	0.08
Cost of Revenue	0.18	0.18	1.04	1.00	1.00	0.45
Gross Profit	1.23	1.18	-1.04	-1.00	-1.00	0.08
Operating Expenses	14.13	14.23	10.05	21.49	34.20	14.12
Operating Profit (EBIT)	-12.90	-13.04	-10.05	-21.49	-34.20	-14.05
Other Income	--	--	--	--	--	--
Profit before Tax	-12.88	-12.28	-10.88	-21.27	-37.57	-13.45
Provision for Tax	-6.66	-0.36	-1.06	3.39	3.39	0.97
Profit after Tax (Net Income)	-11.87	-11.92	-10.68	-21.27	-37.57	-13.45
Minority Interest	1.00	0.36	1.06	--	--	--
Consolidated Profit	--	--	--	--	-37.57	-13.45

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-05	Dec-04
Shareholder's Funds	17.18	17.25	3.19	4.45	4.80	2.35
Minority Interest	1.00	--	--	--	--	--
Non-Current Liabilities	--	0.32	0.53	1.29	1.29	1.65
Current Liabilities	1.82	1.77	4.51	2.17	1.82	2.76
Total Liabilities	21.60	19.84	8.91	7.92	7.92	6.77

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-05	Dec-04
Non-Current Assets	13.88	12.49	7.86	3.97	3.97	4.59
Current Assets	5.91	7.35	1.05	3.94	3.94	2.18
Total Assets	25.69	19.84	8.91	7.92	7.92	6.77
Total Debt*	0.10	0.27	1.40	2.06	1.71	4.08
Net Current Assets	--	5.58	-3.46	2.26	2.12	-0.59

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-05	Dec-04
Cash From Operating Activities	--	-8.60	-6.65	-3.88	-3.88	-4.49
Cash Flow from Investing Activities	--	--	--	--	--	-1.75
Cash from Financing Activities	--	13.74	5.71	5.49	5.49	8.22
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-05	Dec-04
Adjusted EPS ($)	-2.57	-2.81	-5.55	-0.98	-2.63	-1.43
Cash EPS ($)	--	-2.53	-5.01	-0.93	-2.56	-1.39
Adjusted Book Value ($)	--	4.07	1.65	0.20	0.34	0.25
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.03	-3.45	-0.18	-0.27	-0.48
Free Cash Flow per Share ($)	--	-2.03	-3.45	-0.18	-0.27	-0.67

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-05	Dec-04
ROCE (%)	--	-107.84	-192.55	-326.69	-580.65	-796.56
ROE (%)	-73.33	-116.64	-279.65	-459.49	-1,050.44	963.17
ROA (%)	-53.00	-82.90	-126.96	-268.66	-511.87	-380.67
EBIT Margin (%)	-851.59	-853.59	--	--	--	-17,682.86
Net Margin (%)	-839.69	-874.29	--	--	--	-17,932.37
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-05	Dec-04
Revenue Growth (%)	-58.76	--	--	--	-1.00	1.44
EBIT Growth (%)	-9.17	-11.71	50.78	43.36	-181.67	-47.22
Net Profit Growth (%)	-31.73	-11.58	49.78	43.40	-179.38	-46.89
EPS Growth (%)	-20.58	0.49	-4.69	0.63	-0.83	1.00
Book Value Growth (%)	35.07	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-05	Dec-04
Price / Earnings	--	-5.06	-0.99	-0.80	-0.58	-2.82
Price / Book Value	7.53	3.50	3.32	3.84	4.56	16.15
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.64	-5.21	-1.22	-0.76	-0.54	-3.11
Close Price ($)	11.22	14.25	5.50	15.68	30.63	81.00
High Price ($)	21.41	21.41	15.84	43.80	428.40	207.60
Low Price ($)	6.26	3.80	2.32	14.40	20.60	47.00
Market Cap ($ Cr)	102.06	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-05	Dec-04
Debt to Equity	--	0.02	0.44	0.46	0.36	1.74
Short term debt to equity ratio	0.01	0.01	0.39	0.42	0.32	1.03
Current Ratio	3.25	4.16	0.23	1.81	2.16	0.79
Quick Ratio	3.25	--	--	--	--	0.79
Interest Coverage	-21.35	-18.11	-26.29	-196.49	-171.03	-70.87

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-05	Dec-04
Debtors to sales (%)	1.08	0.54	--	--	--	29.05
Asset Turnover	0.06	0.09	--	--	--	0.02
Receivable days	--	6.21	--	--	--	106.10
Inventory Days	--	--	--	--	--	-21.15
Payable days	--	2,182.42	240.68	36.12	42.51	717.55
Cash Conversion Cycle	--	--	--	--	--	-632.60

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.